CME Sponsor:
CME Outfitters, LLC

Location: Live Webinar

Course Directors/Instructors:
Keith P. Klugman, MD, PhD
William H. Foege Professor of Global Health
Rollins School of Public Health
Professor of Medicine, Division
of Infectious Diseases
Emory University School of Medicine
Atlanta, GA

Michael S. Niederman, MD, FACP, FCCP, FCCM
Chairman, Department of Medicine
Winthrop-University Hospital
Professor of Medicine
Vice-Chairman, Department of Medicine
SUNY at Stony Brook
Mineola, NY

Number of Credits:
1.0 AMA PRA Category 1 Credits™

Registration Fee: Free


More Info

Detailed Description:
Pneumococcal disease, which includes pneumococcal pneumonia, meningitis, and bacteremia is associated with substantial morbidity and mortality, and is considered the top killer among vaccine-preventable diseases. Yet, vaccination rates among adults remain suboptimal. The Centers for Disease Control and Prevention has called for increased efforts to vaccinate at-risk populations against pneumococcal disease. Adherence to accepted treatment guidelines and recommendations can provide a framework for improving early recognition, choosing appropriate antibiotic therapy, and implementing vaccination in high-risk populations. In this interactive webcast, expert faculty will outline strategies for early identification of patients at high risk for infection, emphasizing the importance of timely vaccination, and discuss strategies for prevention and treatment of pneumococcal disease supported by current guidelines.

Learning Objectives:
At the end of this CE activity, participants should be able to:
• Recognize the role of vaccination of high-risk population in the prevention of pneumococcal disease.
• Integrate established treatment guidelines into clinical practice to improve prevention and treatment of
pneumococcal disease in high-risk patients.
• Develop strategies to improve early recognition and diagnosis of pneumococcal disease.
(The following learning objectives pertain only to those requesting CNE credit.)
• Recognize the role of vaccination of high-risk population in the prevention of pneumococcal disease.
• Identify established treatment guidelines into clinical practice to improve prevention and treatment of
pneumococcal disease in high-risk patients.
• Describe strategies to improve early recognition and diagnosis of pneumococcal disease.

Intended Audience:
Physicians, physician assistants, nurses, nurse practitioners, pharmacists, with an interest in pneumococcal disease prevention.